Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis

Elizabeth A. Carr, Sharon Spier, Gregg D. Kortz, Eric P. Hoffman

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Objective - Evaluate histories, clinical signs, and laboratory data of 69 horses homozygous by DNA testing for hyperkalemic periodic paralysis (HPP). Design - Cohort study. Sample Population - 69 of 189 horses testing homozygous for HPP between October 1992 and November 1994. Procedure - Questionnaires addressing signalment, training regimes, medical history, and current status of affected horses were sent to owners, trainers, or attending veterinarians. Data from completed questionnaires were tabulated and evaluated, using descriptive statistics. Results - Sixty-nine (37%) of 189 questionnaires were completed and returned. Clinical episodes of muscle weakness or paralysis varied in severity and frequency from mild muscle fasciculations to recumbency and death. Sixty-three of 68 HPP-affected horses were reported to have had stridor associated with exercise, excitement, stress, or episodes of muscle paralysis. Common endoscopie findings in affected horses included pharyngeal collapse, pharyngeal edema, laryngopalatal dislocation, and laryngeal paralysis. Twelve of 27 horses receiving acetazolamide had decreases in stridor while receiving medication. Clinical Implications - Most horses testing homozygous for HPP had clinical signs associated with pharyngeal and laryngeal dysfunction. Hyperkalemic periodic paralysis should be included on a differential list for horses examined for signs of laryngeal or pharyngeal dysfunction or stridor. Treatment with acetazolamide may help to control respiratory tract signs associated with this disease.

Original languageEnglish (US)
Pages (from-to)798-803
Number of pages6
JournalJournal of the American Veterinary Medical Association
Volume209
Issue number4
StatePublished - Aug 15 1996

Fingerprint

Hyperkalemic Periodic Paralysis
paralysis
Horses
horses
Respiratory Sounds
acetazolamide
Acetazolamide
questionnaires
Paralysis
muscles
Fasciculation
medical history
Vocal Cord Paralysis
Muscles
Veterinarians
Muscle Weakness
testing
cohort studies
respiratory system
Respiratory System

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis. / Carr, Elizabeth A.; Spier, Sharon; Kortz, Gregg D.; Hoffman, Eric P.

In: Journal of the American Veterinary Medical Association, Vol. 209, No. 4, 15.08.1996, p. 798-803.

Research output: Contribution to journalArticle

@article{b47021d9ff3e40de80e15889c4da4362,
title = "Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis",
abstract = "Objective - Evaluate histories, clinical signs, and laboratory data of 69 horses homozygous by DNA testing for hyperkalemic periodic paralysis (HPP). Design - Cohort study. Sample Population - 69 of 189 horses testing homozygous for HPP between October 1992 and November 1994. Procedure - Questionnaires addressing signalment, training regimes, medical history, and current status of affected horses were sent to owners, trainers, or attending veterinarians. Data from completed questionnaires were tabulated and evaluated, using descriptive statistics. Results - Sixty-nine (37{\%}) of 189 questionnaires were completed and returned. Clinical episodes of muscle weakness or paralysis varied in severity and frequency from mild muscle fasciculations to recumbency and death. Sixty-three of 68 HPP-affected horses were reported to have had stridor associated with exercise, excitement, stress, or episodes of muscle paralysis. Common endoscopie findings in affected horses included pharyngeal collapse, pharyngeal edema, laryngopalatal dislocation, and laryngeal paralysis. Twelve of 27 horses receiving acetazolamide had decreases in stridor while receiving medication. Clinical Implications - Most horses testing homozygous for HPP had clinical signs associated with pharyngeal and laryngeal dysfunction. Hyperkalemic periodic paralysis should be included on a differential list for horses examined for signs of laryngeal or pharyngeal dysfunction or stridor. Treatment with acetazolamide may help to control respiratory tract signs associated with this disease.",
author = "Carr, {Elizabeth A.} and Sharon Spier and Kortz, {Gregg D.} and Hoffman, {Eric P.}",
year = "1996",
month = "8",
day = "15",
language = "English (US)",
volume = "209",
pages = "798--803",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "4",

}

TY - JOUR

T1 - Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis

AU - Carr, Elizabeth A.

AU - Spier, Sharon

AU - Kortz, Gregg D.

AU - Hoffman, Eric P.

PY - 1996/8/15

Y1 - 1996/8/15

N2 - Objective - Evaluate histories, clinical signs, and laboratory data of 69 horses homozygous by DNA testing for hyperkalemic periodic paralysis (HPP). Design - Cohort study. Sample Population - 69 of 189 horses testing homozygous for HPP between October 1992 and November 1994. Procedure - Questionnaires addressing signalment, training regimes, medical history, and current status of affected horses were sent to owners, trainers, or attending veterinarians. Data from completed questionnaires were tabulated and evaluated, using descriptive statistics. Results - Sixty-nine (37%) of 189 questionnaires were completed and returned. Clinical episodes of muscle weakness or paralysis varied in severity and frequency from mild muscle fasciculations to recumbency and death. Sixty-three of 68 HPP-affected horses were reported to have had stridor associated with exercise, excitement, stress, or episodes of muscle paralysis. Common endoscopie findings in affected horses included pharyngeal collapse, pharyngeal edema, laryngopalatal dislocation, and laryngeal paralysis. Twelve of 27 horses receiving acetazolamide had decreases in stridor while receiving medication. Clinical Implications - Most horses testing homozygous for HPP had clinical signs associated with pharyngeal and laryngeal dysfunction. Hyperkalemic periodic paralysis should be included on a differential list for horses examined for signs of laryngeal or pharyngeal dysfunction or stridor. Treatment with acetazolamide may help to control respiratory tract signs associated with this disease.

AB - Objective - Evaluate histories, clinical signs, and laboratory data of 69 horses homozygous by DNA testing for hyperkalemic periodic paralysis (HPP). Design - Cohort study. Sample Population - 69 of 189 horses testing homozygous for HPP between October 1992 and November 1994. Procedure - Questionnaires addressing signalment, training regimes, medical history, and current status of affected horses were sent to owners, trainers, or attending veterinarians. Data from completed questionnaires were tabulated and evaluated, using descriptive statistics. Results - Sixty-nine (37%) of 189 questionnaires were completed and returned. Clinical episodes of muscle weakness or paralysis varied in severity and frequency from mild muscle fasciculations to recumbency and death. Sixty-three of 68 HPP-affected horses were reported to have had stridor associated with exercise, excitement, stress, or episodes of muscle paralysis. Common endoscopie findings in affected horses included pharyngeal collapse, pharyngeal edema, laryngopalatal dislocation, and laryngeal paralysis. Twelve of 27 horses receiving acetazolamide had decreases in stridor while receiving medication. Clinical Implications - Most horses testing homozygous for HPP had clinical signs associated with pharyngeal and laryngeal dysfunction. Hyperkalemic periodic paralysis should be included on a differential list for horses examined for signs of laryngeal or pharyngeal dysfunction or stridor. Treatment with acetazolamide may help to control respiratory tract signs associated with this disease.

UR - http://www.scopus.com/inward/record.url?scp=0030586687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030586687&partnerID=8YFLogxK

M3 - Article

VL - 209

SP - 798

EP - 803

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 4

ER -